3,138 Studies Reviewed. 77.4% Found Biological Effects. The Evidence is Clear.

Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice.

Bioeffects Seen

Hu Y, Lai J, Wan B, Liu X, Zhang Y, Zhang J, Sun D, Ruan G, Liu E, Liu GP, Chen C, Wang DW. · 2016

View Original Abstract
Share:

Controlled magnetic field exposure at 500 microtesla improved Alzheimer's symptoms in mice, suggesting therapeutic potential under specific conditions.

Plain English Summary

Summary written for general audiences

Researchers exposed genetically modified mice with Alzheimer's disease to extremely low frequency magnetic fields (50Hz, 500μT) for three months daily. The magnetic field exposure improved cognitive function, reduced brain cell death, and decreased tau protein abnormalities that are hallmarks of Alzheimer's disease. This suggests that controlled magnetic field exposure might have therapeutic potential for neurodegenerative conditions.

Why This Matters

This research presents a fascinating paradox in the EMF health debate. While we typically focus on potential harms from magnetic field exposure, this study demonstrates measurable benefits at 500 microtesla (0.5 millitesla) - a level roughly 10 times higher than typical household appliances but similar to what you might experience very close to electrical equipment. The science demonstrates that ELF magnetic fields can influence brain chemistry in ways that could be therapeutically beneficial. What this means for you is that the relationship between EMF exposure and health isn't simply linear or always negative. However, this doesn't negate concerns about chronic, uncontrolled exposure from multiple sources throughout your daily life. The reality is that therapeutic applications require specific frequencies, intensities, and exposure patterns - very different from the chaotic mix of EMF we encounter from modern technology.

Exposure Details

Magnetic Field
0.5 mG
Source/Device
50Hz
Exposure Duration
daily for 3 months.

Exposure Context

This study used 0.5 mG for magnetic fields:

Building Biology guidelines are practitioner-based limits from real-world assessments. BioInitiative Report recommendations are based on peer-reviewed science. Check Your Exposure to compare your own measurements.

Where This Falls on the Concern Scale

Study Exposure Level in ContextA logarithmic scale showing exposure levels relative to Building Biology concern thresholds and regulatory limits.Study Exposure Level in ContextThis study: 0.5 mGExtreme Concern5 mGFCC Limit2,000 mGEffects observed in the Slight Concern range (Building Biology)FCC limit is 4,000x higher than this exposure level

Study Details

The aim of this study is to observe Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice

Transgenic mice (3xTg) were used in the present study. 3xTg mice, which express an APP/PS1 mutation ...

We discovered that ELF-MF exposure ameliorated cognitive deficits and increased synaptic proteins in...

These findings suggest that ELF-MF exposure could act as a valid therapeutic strategy for ameliorating cognitive deficits and attenuating tau hyperphosphorylation in AD.

Cite This Study
Hu Y, Lai J, Wan B, Liu X, Zhang Y, Zhang J, Sun D, Ruan G, Liu E, Liu GP, Chen C, Wang DW. (2016). Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice. Neurotoxicology. 53:290-300, 2016.
Show BibTeX
@article{y_2016_longterm_exposure_to_elfmf_654,
  author = {Hu Y and Lai J and Wan B and Liu X and Zhang Y and Zhang J and Sun D and Ruan G and Liu E and Liu GP and Chen C and Wang DW.},
  title = {Long-term exposure to ELF-MF ameliorates cognitive deficits and attenuates tau hyperphosphorylation in 3xTg AD mice.},
  year = {2016},
  
  url = {https://pubmed.ncbi.nlm.nih.gov/26945731/},
}

Quick Questions About This Study

Researchers exposed genetically modified mice with Alzheimer's disease to extremely low frequency magnetic fields (50Hz, 500μT) for three months daily. The magnetic field exposure improved cognitive function, reduced brain cell death, and decreased tau protein abnormalities that are hallmarks of Alzheimer's disease. This suggests that controlled magnetic field exposure might have therapeutic potential for neurodegenerative conditions.